FAMCICLOVIR 250 MG
FAMCICLOVIR : 250 MG · DIN 02324873 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is FAMCICLOVIR?
FAMCICLOVIR 250 MG contains FAMCICLOVIR : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02324873, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Mar-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02324873 |
|---|---|
| Brand name | FAMCICLOVIR |
| Generic / active ingredient | FAMCICLOVIR : 250 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AB09 FAMCICLOVIR |
| AHFS class | 08:18.32 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Mar-2018 |
| Original market date | 2009-10-16 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code J05AB09 FAMCICLOVIR. 6 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FAMCICLOVIR | 125 MG | TABLET | APOTEX INC | MARKETED | DIN 02292025 |
| APO-FAMCICLOVIR | 250 MG | TABLET | APOTEX INC | MARKETED | DIN 02292041 |
| APO-FAMCICLOVIR | 500 MG | TABLET | APOTEX INC | MARKETED | DIN 02292068 |
| FAMVIR | 125 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02229110 |
| FAMVIR | 250 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02229129 |
| FAMVIR | 500 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02177102 |
| ACT FAMCICLOVIR | 125 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305682 |
| ACT FAMCICLOVIR | 250 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305690 |
| ACT FAMCICLOVIR | 500 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305704 |
| AURO-FAMCICLOVIR | 125 MG | TABLET | AURO PHARMA INC | APPROVED | DIN 02431564 |
Who else supplies FAMCICLOVIR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FAMCICLOVIR appears in 157 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.